SF Journal of Oncology Research focuses on research investigating the biological mechanisms, clinical behavior, diagnosis, and treatment of malignant diseases. The journal brings together investigators and healthcare professionals involved in experimental, translational, and clinical oncology to promote the exchange of knowledge across different areas of cancer research.
The journal covers areas including tumor biology, cancer genetics and genomics, molecular signaling, tumor microenvironment, cancer stem cells, cancer immunology, biomarkers, molecular diagnostics, therapeutic targets, chemotherapy, targeted therapy, immunotherapy, radiotherapy, treatment resistance, precision medicine, and emerging strategies for cancer management.
The journal welcomes all types of scholarly manuscripts relevant to oncology research, including original research, review articles, systematic reviews, translational studies, clinical investigations, case reports, case series, methodological contributions, brief reports, and other scientifically valuable work. The journal seeks to encourage research that connects fundamental discoveries with clinical applications and contributes to improved cancer detection, treatment, and outcomes.
Publishes multidisciplinary oncology research covering tumor biology, diagnosis, biomarkers, cancer therapies, precision medicine, prevention, and supportive care.
